Head-to-head · Cost-Efficiency Index
Novi vs Voxy
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Novi
Shoppers drawn to a low flat headline price who don't need dosing, coverage states or pharmacy details published up front.
Visit NoviVoxy
Shoppers who want to know exactly which pharmacy and medical group stand behind their prescription, with a simple all-in monthly price.
Visit VoxyThe verdict
Novi and Voxy tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers, so choose on fit. Novi: Shoppers drawn to a low flat headline price who don't need dosing, coverage states or pharmacy details published up front. Voxy: Shoppers who want to know exactly which pharmacy and medical group stand behind their prescription, with a simple all-in monthly price.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Novi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Novi | Voxy |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $99/moAll doses, promotional rate, compounded | $175/moCompounded, billed monthly; $99/mo on a 12-month plan |
| Tirzepatide / mo | $133/moAll doses, promotional rate, compounded | $225/moCompounded, billed monthly; $135/mo on a 12-month plan |
| Semaglutide / yr (modeled) | $1,188 | $2,100 |
| Tirzepatide / yr (modeled) | $1,596 | $2,700 |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #133 | #139 |
Novi
69/100Where the value is
- Lowest advertised entry price in this entire batch for both drugs ($99 semaglutide / $133 tirzepatide)
- LegitScript certified, with a link to its record in LegitScript's own lookup
- States one flat price per dose with no separate visit fee and free shipping
The tradeoffs
- Publishes no mg dose, supply length, state list, medical director or compounding pharmacy on its site or help center
- The advertised $99/$133 rate is displayed against a live countdown timer ('price increases in...') next to a claimed $299 original price, a scarcity tactic that makes it unclear whether this is a genuine standing rate or a recurring promotional one
Voxy
69/100Where the value is
- Names its compounding pharmacy (VialsRX in Houston) and its prescribing medical group (Arora Health & Aesthetics) on a public compliance page
- One price includes the provider visit, medication, injection supplies, free shipping and monthly check-ins with dose adjustments
- Full price tables for 1-, 3-, 6- and 12-month plans are shown before you start
The tradeoffs
- The "starting at $99" and "$135" figures are 12-month plans billed annually; month to month it's $175 and $225
- Final pricing is confirmed at checkout after the assessment
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.